Pediatric Research Unit, University of Eastern Finland and Kuopio University Hospital, Kuopio, PL100, 70029 KYS, Finland.
Center for Child Health Research, Tampere University and Department of Pediatrics, Tampere University Hospital, Tampere, Finland.
Pediatr Rheumatol Online J. 2023 Mar 17;21(1):26. doi: 10.1186/s12969-023-00808-9.
In recent years, biologic drug therapies have altered the course of juvenile idiopathic arthritis (JIA) possibly also improving the patients' physical fitness. However, studies measuring both cardiorespiratory and muscular fitness in children with JIA are sparse and have failed to show consistent results. Our aim was to assess both cardiorespiratory and neuromuscular fitness and contributing factors in children and adolescents with JIA in the era of biologic drug therapies.
This cross-sectional study consisted of 73 JIA patients (25 boys, 48 girls) aged 6.8- 17.5 years and 73 healthy age- and sex-matched controls, investigated in 2017-2019. Cardiorespiratory fitness was assessed by maximal ergospirometry and neuromuscular fitness by speed, agility, balance, and muscle strength tests.
Means (± SD) of maximal workload (W) and peak oxygen uptake (VO2) were lower in JIA patients than in controls (W: 2.80 ± 0.54 vs. 3.14 ± 0.50 Watts, p < 0.01; VO2: 38.7 ± 7.53 vs. 45.8 ± 6.59 ml/min/kg, p < 0.01). Shuttle-run, sit-up and standing long jump test results were lower in JIA patients than in controls (p < 0.01). Mean (± SD) daily activity was lower (89.0 ± 44.7 vs. 112.7 ± 62.1 min/day, p < 0.05), and sedentary time was higher (427 ± 213 vs. 343 ± 211 min/day, p < 0.05) in JIA patients compared to controls. Physical activity and cardiorespiratory or neuromuscular fitness were not associated with disease activity.
JIA patients were physically less active and had lower cardiorespiratory and neuromuscular fitness than their same aged controls with no JIA. Therefore, JIA patients should be encouraged to engage in physical activities as a part of their multidisciplinary treatment protocols to prevent adverse health risks of low physical activity and fitness.
近年来,生物药物疗法改变了幼年特发性关节炎(JIA)的病程,可能还提高了患者的身体健康水平。然而,评估 JIA 儿童心肺和肌肉健康的研究很少,且结果不一致。我们的目的是评估生物药物治疗时代 JIA 儿童和青少年的心肺和神经肌肉健康及其影响因素。
本横断面研究纳入了 2017 年至 2019 年期间的 73 名 JIA 患者(25 名男孩,48 名女孩)和 73 名年龄和性别匹配的健康对照者,年龄 6.8-17.5 岁。心肺功能通过最大运动量心肺功能测试进行评估,神经肌肉功能通过速度、敏捷性、平衡和肌肉力量测试进行评估。
JIA 患者的最大工作量(W)和峰值耗氧量(VO2)平均值(±SD)均低于对照组(W:2.80±0.54 与 3.14±0.50 瓦特,p<0.01;VO2:38.7±7.53 与 45.8±6.59 毫升/分钟/千克,p<0.01)。JIA 患者的折返跑、仰卧起坐和立定跳远测试结果均低于对照组(p<0.01)。JIA 患者的平均(±SD)日常活动量(89.0±44.7 与 112.7±62.1 分钟/天,p<0.05)较低,久坐时间(427±213 与 343±211 分钟/天,p<0.05)较高。JIA 患者的身体活动量和心肺或神经肌肉健康与疾病活动无关。
与无 JIA 的同年龄对照组相比,JIA 患者的身体活动量较少,心肺和神经肌肉健康状况较差。因此,应鼓励 JIA 患者参与身体活动,作为其多学科治疗方案的一部分,以预防身体活动量和健康状况不佳带来的不良健康风险。